Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Dry age related macular degeneration is characterized by the presence of age-related deposits called drusen and atrophy.
Biomarker and diagnostic research for dry age related macular degeneration has been reported in the published literature.
4 clinical trials registered, 1 recruiting. Interventions under study include other interventions, drug therapy, and biologic therapy. Pipeline includes 2 PHASE1. Research is primarily industry-sponsored.
223 publications have been identified in PubMed for dry age related macular degeneration. Kisho has analyzed 89 by research type. Research spans Basic Science / Preclinical (35%), Review / Meta-Analysis (18%), and Gene Therapy / Novel Therapeutics (15%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 31 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 9:42 PM UTC
35%
Research summaries | 16 | 18% |
New treatment approaches | 13 | 15% |
Disease patterns and progression | 11 | 12% |
Clinical study results | 9 | 10% |
Testing and diagnosis research | 5 | 6% |
Other research | 2 | 2% |
Patient case studies | 2 | 2% |
Han M (2026). [PMID: 41724259](https://pubmed.ncbi.nlm.nih.gov/41724259/). *Int J Pharm*. [Basic Science / Preclinical]
Shirley M (2026). [PMID: 41335372](https://pubmed.ncbi.nlm.nih.gov/41335372/). *Drugs*. [Review / Meta-Analysis]
Istanaksai A (2026). [PMID: 42137658](https://pubmed.ncbi.nlm.nih.gov/42137658/). *Cureus*. [Review / Meta-Analysis]
Ozturk M (2026). [PMID: 41681740](https://pubmed.ncbi.nlm.nih.gov/41681740/). *Diagnostics (Basel)*. [Gene Therapy / Novel Therapeutics]
Jaffe GJ (2026). [PMID: 41791029](https://pubmed.ncbi.nlm.nih.gov/41791029/). *Retina*. [Clinical Trial Publication]
Savastano MC (2026). [PMID: 41910764](https://pubmed.ncbi.nlm.nih.gov/41910764/). *Graefes Arch Clin Exp Ophthalmol*. [Review / Meta-Analysis]
Palata Rezende M (2026). [PMID: 41100220](https://pubmed.ncbi.nlm.nih.gov/41100220/). *Photobiomodul Photomed Laser Surg*. [Clinical Trial Publication]
Tao L (2026). [PMID: 41390091](https://pubmed.ncbi.nlm.nih.gov/41390091/). *Life Sci*. [Basic Science / Preclinical]
Prenner S (2026). [PMID: 41818453](https://pubmed.ncbi.nlm.nih.gov/41818453/). *Ophthalmic Surg Lasers Imaging Retina*. [Gene Therapy / Novel Therapeutics]
Lin Z (2026). [PMID: 41390041](https://pubmed.ncbi.nlm.nih.gov/41390041/). *Int J Biol Macromol*. [Gene Therapy / Novel Therapeutics]